Plain-English translation of NCT06324136 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers have developed a personalized diagnostic algorithm — a step-by-step strategy — to identify genetic causes of rare kidney disease. This trial is testing whether this approach works well across multiple hospitals and can help more patients get an accurate diagnosis. A correct diagnosis can guide your treatment, help predict your outlook, and identify whether family members should be tested.
Genetic kidney diseases cause about 1 in 5 cases of chronic kidney disease, but many patients never get a confirmed diagnosis. Without knowing the genetic cause, doctors may order unnecessary tests, give treatments that won't help, and miss opportunities to help your family members. This trial aims to prove that the new diagnostic strategy can reliably identify these genetic causes across different hospitals.
You likely qualify if…
You likely don't qualify if…
You will be asked to provide a blood sample (or possibly a small piece of kidney tissue if you've already had a biopsy) so researchers can perform genetic testing. Your medical information and test results will be collected and analyzed using the new diagnostic algorithm. There are no medications to take or long-term visits required — the main commitment is providing the sample and allowing your medical records to be reviewed.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
Italy